Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
Tuttle
R Michael
RM
Endocrinology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. tuttlem@mskcc.org
Tala
Hernan
H
Shah
Jatin
J
Leboeuf
Rebecca
R
Ghossein
Ronald
R
Gonen
Mithat
M
Brokhin
Matvey
M
Omry
Gal
G
Fagin
James A
JA
Shaha
Ashok
A
D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009367:Neoplasm Staging; D012008:Recurrence; D012189:Retrospective Studies; D012307:Risk Factors; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000473:pathology* / Q000628:therapy; D013965:Thyroidectomy
D007457:Iodine Radioisotopes; D013954:Thyroglobulin